Murlentamab (Anti-AMHR2)
Murlentamab (Anti-AMHR2) is a humanized anti-AMHRII antibody targeting AMHRII. It suppresses tumor growth, stimulates the anti-tumor adaptive immune response through naive macrophage orientation and TAM reprogrammation, in ovarian tumor cells. MW :145.5 KD.
| Supplier | Selleck Chemicals |
|---|---|
| Product # | A2590 |
| Sku # | A2590-1mg*5 |
| Pricing | 1mg*5, $970.00 |